Targeting myosin II to alter the disease course of challenging diseases is a research paper published in Cell (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
The Paul G Allen Frontiers Group
Grant: 202401 - 14773
National Institutes of Health
Grant: GM66817
National Institutes of Health
Grant: GM149073
MeSH Terms